These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

598 related items for PubMed ID: 8438294

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. The relationship of nodular endocardial infiltrates (Quilty lesions) to survival, patient age, anti-HLA antibodies, and coronary artery disease following heart transplantation.
    Chu KE, Ho EK, de la Torre L, Vasilescu ER, Marboe CC.
    Cardiovasc Pathol; 2005; 14(4):219-24. PubMed ID: 16009321
    [Abstract] [Full Text] [Related]

  • 23. Recombinant human erythropoietin decreases anti-HLA sensitization and may improve renal allograft outcome: involvement of anti-idiotypic antibody.
    Grimm PC, Sekiya NM, Robertson LS, Robinson BJ, Ettenger RB.
    Transplant Proc; 1991 Feb; 23(1 Pt 1):407-8. PubMed ID: 1990568
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Detailed examination of HLA antibody development on renal allograft failure and function.
    Zhu L, Lee PC, Everly MJ, Terasaki PI.
    Clin Transpl; 2008 Feb; ():171-87. PubMed ID: 19711514
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Utility of post-transplant anti-HLA antibody measurements in pediatric cardiac transplant recipients.
    Xydas S, Yang JK, Burke EM, Chen JM, Addonizio LJ, Mital SR, Itescu S, Hsu DT, Lamour JM.
    J Heart Lung Transplant; 2005 Sep; 24(9):1289-96. PubMed ID: 16143247
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Intact HLA not beta2m-free heavy chain-specific HLA class I antibodies are predictive of graft failure.
    Cai J, Terasaki PI, Anderson N, Lachmann N, Schönemann C.
    Transplantation; 2009 Jul 27; 88(2):226-30. PubMed ID: 19623018
    [Abstract] [Full Text] [Related]

  • 34. HLA class I antibodies in patients awaiting kidney transplantation and the association with renal graft survival.
    Wu HH, Tien YC, Huang CI, Chiang YJ, Chu SH, Lai PC.
    Transplant Proc; 2008 Sep 27; 40(7):2191-4. PubMed ID: 18790188
    [Abstract] [Full Text] [Related]

  • 35. Kidney graft recipients with pretransplantation HLA CLASS I antibodies and high soluble CD30 are at high risk for graft loss.
    Rodríguez LM, París SC, Arbeláez M, Cotes JM, Süsal C, Torres Y, García LF.
    Hum Immunol; 2007 Aug 27; 68(8):652-60. PubMed ID: 17678719
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Donor-specific HLA antibodies after transplantation are associated with deterioration in cardiac function.
    Leech SH, Mather PJ, Eisen HJ, Pina IL, Margulies KB, Bove AA, Jeevanandam V.
    Clin Transplant; 1996 Dec 27; 10(6 Pt 2):639-45. PubMed ID: 8996758
    [Abstract] [Full Text] [Related]

  • 38. [Relevance of posttransplant HLA-II antibodies production on long-term survival of renal allograft].
    Liu ZH, Shen B, Tan JM, Ding YD.
    Zhonghua Yi Xue Za Zhi; 2007 Jul 24; 87(28):1978-80. PubMed ID: 17923038
    [Abstract] [Full Text] [Related]

  • 39. Clinical relevance of Luminex donor-specific crossmatches: data from 165 renal transplants.
    Billen EV, Christiaans MH, van den Berg-Loonen EM.
    Tissue Antigens; 2009 Sep 24; 74(3):205-12. PubMed ID: 19497037
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.